Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bailing Anshen Pian for insomnia (Phase III)
CTR20130942Phase 3Completed
- Sponsor
- Yiling Pharmaceutical
- Start
- Apr 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Bailing Anshen in Insomnia, sponsored by Yiling Pharmaceutical. Started Apr 2014; status: completed.
02
Drugs
Bailing Anshen
03
Conditions
Insomnia
Beyond the preview
Go deeper on CTR20130942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130942.